TrivarX Limited (MDBIF)
TrivarX Limited operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Hawthorn East, VIC, AU. The stock last traded at $0.00, down 89.57% on the session, giving a market capitalisation of $1.8M. On trailing twelve-month figures it carries a trailing P/E of -4.29, a net margin of 0.0%. Its beta of 0.84 implies it has historically moved less than the broad market.
TrivarX Limited operates as a health technology enterprise, focusing on the creation of advanced, AI-driven, and scientifically validated instruments for the detection and diagnosis of behavioral health disorders. The company's reach extends across both Australia and the United States. Beyond its core diagnostic tools, TrivarX provides specialized mental well-being programs tailored for businesses as a corporate health solution, and also develops various products for the wider healthcare provider market. The firm, which was founded in 1987 and is headquartered in Mount Lawley, Australia, changed its name to TrivarX Limited in October 2023, having previously operated under the name Medibio Limited.
TrivarX Limited is most often compared with the following Healthcare names: